Laman Utama532531 • BOM
add
Strides Pharma Science Ltd
Tutup sebelumnya
₹1,642.00
Julat hari
₹1,595.10 - ₹1,652.55
Julat tahun
₹467.40 - ₹1,675.25
Permodalan pasaran
149.79B INR
Bilangan Purata
35.70K
Nisbah P/E
3,338.29
Hasil dividen
0.15%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(INR) | Jun 2024info | Perubahan T/T |
---|---|---|
Hasil | 10.88B | 16.94% |
Perbelanjaan pengendalian | 4.99B | 13.84% |
Pendapatan bersih | 702.02J | 1,086.95% |
Margin untung bersih | 6.46 | 950.00% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 2.24B | 33.22% |
Kadar cukai berkesan | 19.80% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(INR) | Jun 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 2.97B | -19.05% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 20.72B | — |
Syer tertunggak | 91.89J | — |
Harga kepada buku | 7.09 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 9.17% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(INR) | Jun 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 702.02J | 1,086.95% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Diasaskan
1990
Ibu pejabat
Tapak web
Pekerja
3,065